Literature DB >> 11302487

Haliangicin, a novel antifungal metabolite produced by a marine myxobacterium. 1. Fermentation and biological characteristics.

R Fudou1, T Iizuka, S Yamanaka.   

Abstract

Haliangicin, a novel beta-methoxyacrylate antibiotic with a conjugated tetraene moiety, was isolated from the culture broth of a marine myxobacterium. A bacterium tentatively named as Haliangium luteum required 2-3% NaCl for the growth and production of haliangicin. Haliangicin inhibits the growth of a wide spectrum of fungi but was inactive against bacteria. In mitochondrial respiratory chains, haliangicin interfered the electron flow within the cytochrome b-c1 segment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11302487     DOI: 10.7164/antibiotics.54.149

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  17 in total

Review 1.  Alternative sources of biologically active substances.

Authors:  V Bĕhal
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

Review 2.  Development of antibiotics and the future of marine microorganisms to stem the tide of antibiotic resistance.

Authors:  Noer Kasanah; Mark T Hamann
Journal:  Curr Opin Investig Drugs       Date:  2004-08

3.  Marine myxobacteria as a source of antibiotics--comparison of physiology, polyketide-type genes and antibiotic production of three new isolates of Enhygromyxa salina.

Authors:  Till F Schäberle; Emilie Goralski; Edith Neu; Ozlem Erol; Georg Hölzl; Peter Dörmann; Gabriele Bierbaum; Gabriele M König
Journal:  Mar Drugs       Date:  2010-09-03       Impact factor: 5.118

Review 4.  Scrutinizing the scaffolds of marine biosynthetics from different source organisms: Gram-negative cultured bacterial products enter center stage.

Authors:  Patrick C Still; Tyler A Johnson; Christine M Theodore; Steven T Loveridge; Phillip Crews
Journal:  J Nat Prod       Date:  2014-02-26       Impact factor: 4.050

5.  A new antibacterial amino phenyl pyrrolidone derivative from a novel marine gliding bacterium Rapidithrix thailandica.

Authors:  Yutthapong Sangnoi; Anuchit Plubrukarn; Vullapa Arunpairojana; Akkharawit Kanjana-Opas
Journal:  World J Microbiol Biotechnol       Date:  2013-10-27       Impact factor: 3.312

6.  Heterologous Production of the Marine Myxobacterial Antibiotic Haliangicin and Its Unnatural Analogues Generated by Engineering of the Biochemical Pathway.

Authors:  Yuwei Sun; Zhiyang Feng; Tomohiko Tomura; Akira Suzuki; Seishi Miyano; Takashi Tsuge; Hitoshi Mori; Joo-Won Suh; Takashi Iizuka; Ryosuke Fudou; Makoto Ojika
Journal:  Sci Rep       Date:  2016-02-26       Impact factor: 4.379

7.  An Unusual Diterpene-Enhygromic Acid and Deoxyenhygrolides from a Marine Myxobacterium, Enhygromyxa sp.

Authors:  Tomohiko Tomura; Shiori Nagashima; Satoshi Yamazaki; Takashi Iizuka; Ryosuke Fudou; Makoto Ojika
Journal:  Mar Drugs       Date:  2017-04-06       Impact factor: 5.118

Review 8.  Future Directions of Marine Myxobacterial Natural Product Discovery Inferred from Metagenomics.

Authors:  Ronald Garcia; James J La Clair; Rolf Müller
Journal:  Mar Drugs       Date:  2018-08-29       Impact factor: 5.118

Review 9.  Investigating the Biosynthesis of Natural Products from Marine Proteobacteria: A Survey of Molecules and Strategies.

Authors:  Marshall L Timmermans; Yagya P Paudel; Avena C Ross
Journal:  Mar Drugs       Date:  2017-08-01       Impact factor: 5.118

Review 10.  Metabolic and Biosynthetic Diversity in Marine Myxobacteria.

Authors:  Katja Gemperlein; Nestor Zaburannyi; Ronald Garcia; James J La Clair; Rolf Müller
Journal:  Mar Drugs       Date:  2018-09-05       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.